Generate professional replies, appeals, opinions to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
XBRL filing requirement mandates electronic submission of pharmaceutical industry cost compliance reports using prescribed Form A XBRL. Amendments to the Cost Accounting Records (Pharmaceutical Industry) Rules, 2011 (effective 2 December 2012) redefine clauses to introduce Form A XBRL for electronic filing, replace Form A with FORM A XBRL, and define Form B and Product or Activity Group. FORM A XBRL prescribes mandatory corporate identifiers, financial year, attachment of the XBRL compliance report, a verification statement, digital signature by an authorised signatory with specified identification, and details of the cost accountant including employment/practice status and membership.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
XBRL filing requirement mandates electronic submission of pharmaceutical industry cost compliance reports using prescribed Form A XBRL.
Amendments to the Cost Accounting Records (Pharmaceutical Industry) Rules, 2011 (effective 2 December 2012) redefine clauses to introduce Form A XBRL for electronic filing, replace Form A with FORM A XBRL, and define Form B and Product or Activity Group. FORM A XBRL prescribes mandatory corporate identifiers, financial year, attachment of the XBRL compliance report, a verification statement, digital signature by an authorised signatory with specified identification, and details of the cost accountant including employment/practice status and membership.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.